Vaccine safety: what systems are required to ensure public confidence in vaccines?
- PMID: 35843626
- PMCID: PMC9349887
- DOI: 10.5694/mja2.51662
Vaccine safety: what systems are required to ensure public confidence in vaccines?
Keywords: Adverse drug reactions; Public health; Surveillance; Vaccination.
Comment on
-
The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.Med J Aust. 2022 Aug 15;217(4):195-202. doi: 10.5694/mja2.51619. Epub 2022 Jul 4. Med J Aust. 2022. PMID: 35781813 Free PMC article.
References
-
- Gold MS, Effler P, Kelly H, et al. Febrile convulsions after 2010 seasonal trivalent influenza vaccine: implications for vaccine safety surveillance in Australia. Med J Aust 2010; 193: 492‐493. https://www.mja.com.au/journal/2010/193/9/febrile‐convulsions‐after‐2010... - PubMed
-
- Clothier HJ, Crawford NW, Russell M, et al. Evaluation of “SAEFVIC”, a pharmacovigilance surveillance scheme for the spontaneous reporting of adverse events following immunisation in Victoria, Australia. Drug Saf 2017; 40: 483‐495. - PubMed
-
- World Health Organization . Causality assessment of an adverse event following immunization (AEFI): user manual for the revised WHO classification. 2nd edition, 2019. update. https://www.who.int/publications/i/item/9789241516990 (viewed June 2022).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
